ライフサイエンスコーパス: clinical stage

1 t (P = 0.007 in early and P = 0.0048 in late clinical stages).

2 tion drug candidates from the preclinical to clinical stage.

3 disease progression shown to correlate with clinical stage.

4 er at the target site, are mostly at the pre-clinical stage.

5 rogeneous among the patients with MF in each clinical stage.

6 aches are being pursued and have reached the clinical stage.

7 tate-specific antigen level, ISUP grade, and clinical stage.

8 er DFS (HR = 0.19; P = 0.011) independent of clinical stage.

9 cluding those unique to and abundant in each clinical stage.

10 036 was associated with N classification and clinical stage.

11 from mechanical tissue substrates among ARVC clinical stages.

12 y, the infection is chronic, with subsequent clinical stages.

13 ich side effect information for drugs at all clinical stages.

14 is, on the basis of the subclassification in clinical stages.

15 t differed considerably among treatments and clinical stages.

16 ne of these products has yet progressed into clinical stages.

17 nteritis that traverses both subclinical and clinical stages.

18 G was significantly associated with advanced clinical stages.

19 t from abnormal prenatal beginnings to early clinical stages.

20 phocytes of OSCC patients with early or late clinical staging.

21 World Health Organization classification and clinical staging.

22 gible for sphincter-sparing surgery based on clinical staging.

23 men included in the study, 363 (98%) had WHO clinical stage 1 disease, 364 (99%) had high functional

24 tre, prospective, cohort study patients with clinical stage 1 endometrial cancer of all histologies a

25 ll tolerated when given to children with WHO clinical stage 1 or 2 HIV disease along with high antire

26 In analysis of only WHO clinical stage 1 or 2 HIV-infected children (n = 68), si

27 on activity of most other HAP, including the clinical stage 2-nitroimidazole mustard TH-302, dinitrob

28 es were eligible if they reported death, WHO clinical stage 3 or 4 events, admittance to hospital, se

29 more advanced HIV (World Health Organization clinical stage 3 or 4) disease had lower mortality in cl

30 hypospadias, and micropenis consistent with clinical stage 3 partial androgen insensitivity.

31 Among the index patients, 76% had clinical stage 3, 4, or 5 FEVR and 24% had stage 1 or 2

32 The crude incidence of histological or clinical stage 3-4 acute intestinal GvHD until day 100 o

33 Histologic and clinical stage 3-4 intestinal GvHD after 12 months occur

34 CD4 cell counts or World Health Organization clinical stage 3/4 disease.

35 endpoint of death, World Health Organization clinical stage 4 disease, or CD4(+) counts of <200/mm(3)

36 s (54 died, 45 had World Health Organization clinical stage 4 events, and 49 had poor immunological r

37 d new or recurrent World Health Organization clinical stage 4 events, or had poor immunological respo

38 rom LRR at 5 years ranged from 86% to 97% by clinical stage, 86% to 97% by pathologic stage, and 71%

39 In addition to clinical staging, a number of biomarkers predicting over

40 We compared the distribution of grade and clinical stage across the pre-PSA and PSA screening eras

41 c physiological and HRCT variables to form a clinical staging algorithm predictive of mortality in a

42 was significantly higher with more advanced clinical stage (Alzheimer's disease > mild cognitive imp

43 -to-lead and lead optimization campaigns and clinical stage and approved drugs, reflecting their incr

44 nitiation, cumulative time with NVL, and WHO clinical stage and CD4 cell count at ART initiation, rat

45 arian cancer patients present at an advanced clinical stage and develop resistance to standard of car

46 After adjusting for clinical stage and grade (likely intermediates of the re

47 omarker of GI GVHD that can be combined with clinical stage and histologic grade to improve risk stra

48 More advanced clinical stage and later year of diagnosis were the only

49 cal risk factors, expression was linked with clinical stage and lymphatic metastasis.

50 l relies on conventional parameters (such as clinical stage and lymphocyte doubling time).

51 pathways involved in preeclampsia at the pre-clinical stage and may be used for the prediction of pre

52 .01) in Cox multivariate analysis, including clinical stage and pathological grade.

53 t its overexpression is correlated with late clinical stage and predicts poor prognosis in ESCC patie

54 24A1, and ROR in relation to melanin levels, clinical stage and prognosis.

55 ency of lymph node metastasis increased with clinical stage and was similar to that in historical sur

56 ifferences of clinical outcome in respective clinical stages and individual 'stage, size, grade and n

57 can progress over years through a series of clinical stages and lead to irreversible neurological or

58 grative topological measures correlated with clinical stages and prognosis, which was further validat

59 could be used as a personalized variable for clinical staging and aphasia treatment planning.

60 e findings may potentially contribute to the clinical staging and monitoring of Stargardt disease.

61 m prostate-specific antigen, tumor grade and clinical stage) and by treatment type (radical prostatec

62 Demographics, distribution of clinical stage, and cause of death did not differ betwee

63 were stratified by hormone receptor status, clinical stage, and chemotherapy regimen.

64 ions were comparable for age, comorbidities, clinical stage, and elevated biomarkers of systemic infl

65 correlated with larger tumor size, advanced clinical stage, and low survival rate in OSCC patients.

66 corresponding antigens, functional pathways, clinical stage, and outcome were examined.

67 lonic disease at presentation, tumor height, clinical stage, and pelvic radiation.

68 ng centre, largest radiological tumour size, clinical stage, and prespecified chemotherapy regimen.

69 with poorer tumor differentiation, advanced clinical stage, and shorter patient survival.

70 tatus, histologic subtype, T stage, N stage, clinical stage, and treatment method.

71 m SUV, performance status, T stage, N stage, clinical stage, and treatment type (surgery vs other) we

72 ultiple tumor niches, their association with clinical stages, and their potential use in cancer diagn

73 heir sample size, lack of clearly documented clinical staging, and lack of well-defined gold standard

74 The condition was classified into 4 clinical stages: annular anterior capsule thickening wit

75 s to address the mechanism of action of four clinical stage anti-Abeta antibodies, aducanumab, ganten

76 in structures of a large set of post-phase-I clinical-stage antibody therapeutics (CSTs) and calculat

77 like DZB, should be further evaluated at the clinical stage as targeted therapy for CCA treatment.

78 ty of Urological Pathology (ISUP) grade, and clinical stage as traditional risk stratification parame

79 ntification and treatment of AD in the early clinical stages as well as before cognitive symptoms eme

80 Starting from a clinical-stage asymmetric disulfide lead, we have identi

81 e, year of ART initiation, CD4 count and WHO clinical stage at ART initiation, retention in HIV care

82 after neoadjuvant chemotherapy, rather than clinical stage at presentation.

83 therapy determines prognosis rather than the clinical stage before neoadjuvant chemotherapy, indicati

84 hibitor that is more potent than three major clinical stage BET inhibitors BMS-986158, OTX-015, and G

85 prognostic models: one with CD4 cell count, clinical stage, bodyweight, age, and sex (CD4 count mode

86 to improve the decision making at the early clinical stage by using innovation and the high-profile

87 V Centers for Disease Control and Prevention clinical stage C (2.88 [1.74-4.79], P < 10(-3) ).

88 Voruciclib, an orally bioavailable clinical stage CDK-selective inhibitor, potently blocks

89 e in vivo efficacies notably superior to the clinical stage compound pretomanid (PA-824).

90 This clinical stage compound was shown to bind the minimal ca

91 They discovered ONC201, a clinical-stage compound, as a potent activator of ClpP a

92 acy are lower than that achieved in liver by clinical-stage compounds.

93 ing for known survival covariates, including clinical staging criteria, the IHC panel remained an ind

94 nt chemotherapy on the basis of pretreatment clinical stage (CS), estrogen receptor status (E), grade

95 ating the American Joint Committee on Cancer clinical stage (CS), final pathologic stage (PS), estrog

96 ohort study of 1386 men with favorable-risk (clinical stage cT1 to cT2bN0M0, prostate-specific antige

97 en (</=80 years) diagnosed in 2011-2012 with clinical stage cT1-2, localized prostate cancer, with pr

98 te cancer and 619 men with unfavorable-risk (clinical stage cT2cN0M0, PSA of 20-50 ng/mL, or Grade Gr

99 n of CRT to surgical resection, adjusted for clinical stage, demographic information, and CRT regimen

100 strains and are constituents of vaccines in clinical-stage development, these findings will aid in r

101 sms in common, and then assesses the various clinical-stage diabetes drugs for their potential activi

102 ic variability, which can make diagnosis and clinical staging difficult.

103 in has made it a challenging target, with no clinical stage, direct small-molecule MYC inhibitors ava

104 The clinical-stage drug candidate Q203 interferes with the f

105 The discovery of the clinical stage, dual FAK/ALK inhibitor 27b, including de

106 have delivered inhibitors reaching advanced clinical stages due to several challenges in the discove

107 us knowledge, and linkage to care) and three clinical stages (eligibility for antiretroviral therapy

108 relation to Parkinson disease diagnoses at 3 clinical stages: established (cases diagnosed before 199

109 iding preclinical support for the use of the clinical stage FAK/PYK2 inhibitors for treatment of MM,

110 s after diagnosis, while currently available clinical staging for esophageal cancer is lacking necess

111 Clinical stages (Gass clinical classification) were dist

112 ls of p-IRAK-4 levels did not correlate with clinical stage, gender, or age, but attenuated IRAK-1,-4

113 found with estimated dose or type of statin, clinical stage, Gleason score, or with prediagnosis stat

114 , histologic type of the tumor, T stage, and clinical stage had no influence on relapse (P = 0.180, P

115 gence of resistance observed for the current clinical-stage hepatitis C virus (HCV) NS3 protease inhi

116 abnormalities included CD4 cell count nadir, clinical staging, history of AIDS-defining events, infec

117 n this study, we use BIVV009 (Sutimlimab), a clinical stage, humanized mAb that specifically inhibits

118 Clinical stage I (CSI) nonseminoma (NS) is a disease lim

119 etrospective study including data from 2,483 clinical stage I (CSI) patients, 1,139 CSI nonseminoma a

120 n 1997 and 2002, 502 patients with suspected clinical stage I (T1-2N0M0) NSCLC were prospectively enr

121 y 1999, 636 women (age >/= 70 years) who had clinical stage I (T1N0M0 according to TNM classification

122 A total of 8772 patients with clinical stage I 0.50 to 1.0 mm thin melanoma undergoing

123 ients with carcinoma in situ and 39,941 with clinical stage I cancer.

124 nd retroperitoneal lymph node dissection for clinical stage I disease in January 2010, which revealed

125 Five patients had clinical stage I disease, 12 had stage II, and three had

126 h seminoma and 257 with nonseminoma; 371 had clinical stage I disease, 201 had systemic disease, and

127 risk lung nodules (n = 4), and management of clinical stage I non-small cell lung cancer (n = 1) were

128 Of 35 patients enrolled, 33 (94%) had clinical stage I NSCLC and two (6%) had clinical stage I

129 toneum is the most common site of relapse in clinical stage I NSGCT on AS.

130 ber 1980 to December 2015, 580 patients with clinical stage I NSGCT were treated with AS, and 162 sub

131 ts and Methods Adult patients with resected, clinical stage I or II adenocarcinoma of the head of the

132 Results We identified 15,237 patients with clinical stage I or II resected pancreatic head adenocar

133 nce a relapse after adjuvant carboplatin for clinical stage I seminoma can be successfully treated wi

134 gies that may follow inguinal orchiectomy in clinical stage I seminoma.

135 s) with limited-stage small-cell lung cancer clinical stage I to III who received CT or CRT were iden

136 isease in 1 of 20 (5%) patients with initial clinical stage I, 2 of 44 (5%) stage IIA, 8 of 47 (17%)

137 ive cohort study of patients <=85 years with clinical stage I-II PDAC in the 2004 to 2014 National Ca

138 Patients age 15 to 70 years with untreated clinical stage I/II HL were eligible.

139 ment resulted in fewer early progressions in clinical stage I/II HL, although early outcome was excel

140 ment is standard treatment for patients with clinical stage I/II Hodgkin lymphoma (HL).

141 is available concerning localized-stage FL (clinical stages I/II), which accounts for ~20% of newly

142 vival rates of patients with first, primary, clinical stage IA nonsmall cell lung cancer from a large

143 l study of 787 patients with newly diagnosed clinical stage IB or II melanoma, we estimated odds rati

144 PATIENTS AND METHODS Patients with clinical stage IB-IIIA NSCLC (excluding superior sulcus

145 Patients operated on for clinical stage II and III rectal cancer were selected fr

146 had clinical stage I NSCLC and two (6%) had clinical stage II NSCLC.

147 2 trial of neoadjuvant therapy for high-risk clinical stage II or III breast cancer, evaluated multip

148 Ninety-eight consecutive patients with clinical stage II or III ER+/HER2- breast cancer were in

149 Patients with clinical stage II or III rectal cancer who were undergoi

150 A total of 486 patients with clinical stage II or III rectal cancer within 12 cm of t

151 Eligible patients had clinical stage II-III (> or = T2 and/or > or = N1) newly

152 ts in the independent validation cohort (99% clinical stage II-III) who were predicted to be treatmen

153 Of 607 patients presenting with clinical stage II/III disease, chemotherapy downstaged 3

154 lysis of patients with locoregional disease (clinical stage II/III) demonstrated that females receive

155 erapy achieves low local recurrence rates in clinical stages II to III rectal cancer, it delays admin

156 For selected patients with clinical stages II to III rectal cancer, neoadjuvant che

157 the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage II

158 l surgery improved survival in patients with clinical stage IIB/IIIA NSCLC.

159 uidelines consider (18)F-FDG PET/CT for only clinical stage III breast cancer patients.

160 receiving CRT decreased with increasing age, clinical stage III disease, female sex, and the presence

161 gressive (biopsy Gleason score >/= 7, and/or clinical stage III or greater, and/or fatal).

162 G PET/CT (or (18)F-FDG PET) in patients with clinical stage III or II breast cancer.

163 variate analysis, an age less than 50 years, clinical stage III, grade 3, estrogen receptor (ER)-nega

164 re with risk factors (RFs) of early relapse, clinical stage III/IV, and anemia identified patients wi

165 icular lymphomas (FLs) diagnosed in advanced clinical stages III/IV, and which are frequently charact

166 Overall, (18)F-FDG PET/CT changed the clinical stage in 61 patients (52%).

167 ditional prognostic information over TLG and clinical staging in patients with advanced T-stage OPSCC

168 er MTV and TGA add prognostic information to clinical staging in patients with oral and oropharyngeal

169 The use of clinical staging in the fatal neurodegenerative disease

170 ck of a suitable animal model, mimicking all clinical stages, in particular the healing process, rema

171 id sequences from 137 antibodies in advanced clinical stages, including 48 approved for therapeutic u

172 We also review approved and clinical-stage intratumoral therapies and consider how t

173 ms certain that some of them will advance to clinical stage investigations.

174 ted by FDG-PET in cervical cancer relates to clinical stage, is comparable to historical data, and st

175 Women diagnosed with clinical stage IV breast cancer from 2003 to 2012 were i

176 Furthermore, advanced clinical stage, lack of p16 expression, and MYC and CCND

177 n and their contribution to pathological and clinical stages leading to vision loss in diabetic retin

178 o detect MGA expression, especially in early clinical stage, low grade and lymph node metastasis-nega

179 ate cancer, as assessed by low-risk disease (clinical stage </=T2a, biopsy Gleason score </=6, and pr

180 n [PSA], <=15 ng/mL; Gleason score, <=3 + 4; clinical stage, <=T2c; lesion size at multiparametric MR

181 SRK-015 is a clinical-stage mAb that prevents extracellular proteolyt

182 , preclinical, and clinical studies of these clinical-stage MDM2 inhibitors.

183 isting evidence, although scarce, supports a clinical staging model by which at-risk women are manage

184 morbidity Index, tumor type, tumor location, clinical stage, neoadjuvant treatment, and the hospital

185 NFL concentration is increased by the early clinical stage of AD and is associated with cognitive de

186 dysfunction and SR Ca(2+) leak depend on the clinical stage of AF or specific animal model studied.

187 eurogranin is increased already at the early clinical stage of Alzheimer's disease and predicts cogni

188 presence of these lesions did not change the clinical stage of any patient and did not affect treatme

189 Evolution of visual acuity and clinical stage of BVMD correlated to OCT measurement par

190 onic liver failure (ACLF) is the most severe clinical stage of cirrhosis, there is lack of informatio

191 ed tomography scan, the tumor was assigned a clinical stage of cT2N0.

192 ET/CT has no impact in the definition of the clinical stage of disease and minimal impact in the trea

193 ple with an increased risk of developing the clinical stage of glaucoma.

194 e of HCC patients, and which correlated with clinical stage of HCC, were NAA, dimethylglycine, 1-meth

195 ly correlated with lymph node metastasis and clinical stage of NPC.

196 ce of subclinical motor dysfunction at a pre-clinical stage of SCA6.

197 ation carriers, in the later preclinical and clinical stages of ADAD, mutation-carrying children were

198 out the brain during asymptomatic as well as clinical stages of Alzheimer disease calls for precise l

199 ognitive dysfunction(7), including the early clinical stages of Alzheimer's disease(5,8-10).

200 fferent AD biomarkers in the preclinical and clinical stages of autosomal dominant AD.

201 tween the expression levels of EcSOD and the clinical stages of breast cancer.

202 nt signaling events in patients at different clinical stages of chronic chagasic heart disease.

203 effector and regulatory responses can define clinical stages of chronic hepatitis B (CHB).

204 linguistic impairment through the successive clinical stages of disease.

205 pies presents a substantial challenge in the clinical stages of drug development for oncology.

206 slation of knowledge between preclinical and clinical stages of drug development.

207 to identify human Tregs and the diversity of clinical stages of HIV infection.

208 these changes are present from the earliest clinical stages of multiple sclerosis; (ii) they occur i

209 ly associated with pathological and advanced clinical stages of NPC.

210 relation between EPO serum concentration and clinical stages of PDR, suggest that erythropoietin repr

211 Our results suggest that at clinical stages of prion infection, dysregulation of res

212 of 12-HETER1 positively correlates with the clinical stages of prostate cancers and Gleason scores.

213 rbation, is affected at the pre-clinical and clinical stages of spinocerebellar ataxia type 6 (SCA6),

214 entified as a good tumor-specific marker for clinical staging of cervical sentinel lymph nodes in hea

215 Specific IVCM-MF correlate with ACD and clinical staging of disease, and are prognostic indicato

216 ales and 72 % were in the Stage 3 of the WHO Clinical Staging of HIV infection.

217 Clinical staging of MacTel was based on best-corrected v

218 Quantitative assessment can enhance the clinical staging of MPM.

219 terion that is currently lacking in the AJCC clinical staging of MPM.Supplemental material is availab

220 ognostic marker suitable and easy to use for clinical staging of patients with EC.

221 emodeling that may find applicability in the clinical staging of TB patients.

222 ter neoadjuvant chemotherapy than presenting clinical stage or final pathologic stage.

223 rimary samples studied irrespective of their clinical stage or prognostic marker phenotype.

224 y of drugs encompassing approximately 12,000 clinical-stage or Food and Drug Administration (FDA)-app

225 ing iron availability by VIT-2763, the first clinical stage oral ferroportin inhibitor, ameliorated a

226 sion levels of KISS1 in PCas correlated with clinical stage (P < 0.01) and with KISS1R expression (P

227 002), and American Joint Committee on Cancer clinical stage (P = .02).

228 survival rates when comparing the presenting clinical stage (P = NS).

229 omes derived from multivariate analysis were clinical stage (P<0.0001), location of the tumor (P=0.02

230 (P= 0.98), histologic subtype (P= 0.17), or clinical stage (P= 0.097).

231 NMRP expression were evident at the earliest clinical stages (p < 0.05), which progressed significant

232 m had the greatest prognostic impact in late clinical stages (P = 0.006).

233 expression was significantly associated with clinical stage, pathologic tumor status, distant metasta

234 Owing to limitations in clinical staging, patients with T1 bladder cancer are at

235 y, which in general is much lower than other clinical stage PI3K inhibitors.

236 Intravenous infusion of the clinical-stage POL5551 analogue POL6326 (3 mg/kg at 4, 6

237 neoadjuvant chemotherapy using pretreatment clinical stage, posttreatment pathologic stage, estrogen

238 These results should improve MRI-guided clinical staging, presurgical planning, and intraoperati

239 rly clinical stage primary INS, whereas late clinical stage primary INS resembled the genetic profile

240 enetic profiles in normal pancreas and early clinical stage primary INS, whereas late clinical stage

241 iR levels were significantly associated with clinical stage, primary tumor size, and response to trea

242 rmed before surgery or biopsy as part of the clinical staging procedure.

243 nostic factors including high Gleason score, clinical stage, prostate-specific antigen (PSA) and exte

244 We stratified randomisation by clinical stage, receptor status, and country and used pe

245 Clinical stage, risk assessment, and treatment plan were

246 In a multivariate analysis, advanced clinical stage, severe histologic damage, and high REG3a

247 pproaching 25% depending on quantitative and clinical stage, sex and histological subtype and is bett

248 Studies involving a clinical-stage small-molecule inhibitor, mavacamten, sho

249 eral regions was correlated highly with FECD clinical stage (Spearman's rho = 0.813, 0.793, and 0.721

250 ed hazard ratio 0.21, 95% CI 0.17-0.27), WHO clinical stage (stages III-IV vs I-II; 3.45, 2.43-4.90),

251 ed system based on World Health Organization clinical staging, standardized first-line ART regimens,

252 ed, with the same number of patients in each clinical stage subgroup (12 stage I patients, 32 stage I

253 reviewed, and the DMR was recorded for each clinical stage subgroup (stages I-III).

254 seventh edition tumor-node-metastasis (TNM) clinical staging system for OAL and followed every 6 to

255 sus-host disease (GvHD) is based on either a clinical staging system or histological or endoscopic fi

256 he American Joint Committee on Cancer (AJCC) clinical staging system, T3 and T2 lesions portended a h

257 86-19 ('Study 19') to examine the utility of clinical staging systems as end points in clinical trial

258 40 to 80 years with a GS between 2 and 6 and clinical stage T1 or T2 prostate cancer enrolled between

259 CI, 0.94-2.03), as did current smokers with clinical stage T1 through T3 (HR, 1.41; 95% CI, 0.80-2.4

260 CI], 1.11-2.32), as did current smokers with clinical stage T1 through T3 (HR, 1.80; 95% CI, 1.04-3.1

261 Early GBC included clinical stage T1/T2.

262 cohort study of Medicare beneficiaries with clinical stage T1a kidney cancer treated with partial or

263 ewly diagnosed LPCa with Gleason score <= 7, clinical stage T1b to T3a, and prostate-specific antigen

264 However, for clinical stage T1b tumors this provides a unique challen

265 performed with or without hilar clamping for clinical stage T1b tumors.

266 with esophageal adenocarcinoma histology and clinical stage T1bN1-N3 or T2-T4aN-/+M0 were divided int

267 t, 2 cm or greater in diameter by palpation, clinical stage T1c-3, cN0, cN1, or cN2a, without metasta

268 ed from 2004 to 2007 with low-risk prostate (clinical stage T1c/T2a; Gleason score, </=6; and prostat

269 Patients with clinical stages T1c-T3b prostate cancer were treated wit

270 a were for very-low-risk cancers, defined by clinical stage (T1c), prostate-specific antigen density

271 ery-low-risk (subset of the low-risk group) (clinical stage, T1c; Gleason score, </=6; prostate-speci

272 reated low-volume low-grade prostate cancer (clinical stage T2a or lower; Gleason score, 3+3; index t

273 Eligible patients had clinical-stage T3 rectal adenocarcinoma within 12 cm of

274 otential advantage of extended resection for clinical stage T4b gastric adenocarcinoma with good long

275 adjuvant therapy, but limitations in current clinical staging techniques mean nodal metastases often

276 th higher odds of Parkinson disease at all 3 clinical stages: the odds ratios comparing long nappers

277 In addition to clinical stage, these parameters could represent the min

278 le across manifest HD from early to advanced clinical staging through metabolomic analysis by mass sp

279 related with histological subtype of OC, but clinical staging, TLG, and SUV(max) values were not rela

280 astasis suppressive activity of entolimod, a clinical stage TLR5 agonist that activates NF-kappaB-, A

281 onella flagellin structurally analogous to a clinical stage TLR5 agonist, entolimod.

282 , and we classified patients by tumour site, clinical stage (TNM system), and post-surgical stage (In

283 SA) concentration, biopsy Gleason grade, and clinical stage to classify patients as low, intermediate

284 y dismal clinical outcomes, independently of clinical stage, TP53 aberrations (deletion of chromosome

285 ected included demographics, diagnosis date, clinical stage, treatment, and outcome 1,082 patients me

286 th tGIV and pYGIV showed no correlation with clinical stage, tumor size, pathologic type, lymph node

287 epithelioid histology, T stage, quantitative clinical stage/tumor volume staging, adjuvant chemothera

288 (24%) had germline BRCA1 or BRCA2 mutations; clinical stage was I (13%), IIA (36%), IIB (36%), and II

289 Clinical stage was I for 19%, II for 63%, and III for 18

290 The distribution of clinical stages was: I, 2.2% II, 3.4% III, 13% IVa, 27%

291 Clinical staging was more helpful in predicting outcome

292 Clinical staging was the best predictive method and no i

293 To advance the therapy to clinical stage, we generated new stable vectors in AAV8

294 Lower CD4, older age, and advanced clinical stage were associated with higher sCD14.

295 s in the cascade, the transitions across the clinical stages were fast.

296 The CD4 + T cell count and WHO clinical staging were determined.

297 utation status, CD38 or ZAP-70 cytogenetics, clinical stage) were significantly associated with time

298 ups (PSA concentration, Gleason grading, and clinical stage) were then used to sub-stratify within ea

299 e primarily associated with tumor burden and clinical stage, whereas tumor TLG is the best predictor

300 ic and prognostic tool for AD, regardless of clinical stage, which would be of great benefit in clini